Skip to main content
. 2022 Jul 18;13:891178. doi: 10.3389/fphar.2022.891178

TABLE 2.

Use of antithrombotic agents among study population.

Overall (n = 6,140)
Antithrombotic agents (n, %) 3,805 (62.0)
Anticoagulant agents (n, %) 3,517 (57.3)
Anticoagulant agents only 3,114 (50.7)
Heparin (n, %) 3,497 (57.0)
UFH only 2,101 (34.2)
LMWH only 920 (15.0)
LMWH and UFH 476 (7.8)
Antiplatelet agents (n, %) 691 (11.3)
Antiplatelet agents only 288 (4.7)

UFH: unfractionated heparin; LWMH: low molecular weight heparin.